Psych Exam 2 Anxiety-Related Disorders (Waters)

0.0(0)
studied byStudied by 0 people
full-widthCall with Kai
GameKnowt Play
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/141

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

142 Terms

1
New cards

definition of anxiety

· psychological, physiological, and behavioral state in animals and humans (normal)

o Caused by perceived threat to well-being or survival

o Facilities coping with adverse or unexpected situations

2
New cards

what are the 4 types of anxiety-related disorders?

· Generalized anxiety disorder (GAD)

· Panic disorder (PD)

· Social anxiety disorder (SAD)

· Posttraumatic stress disorder (PTSD) --> not truly an anxiety disorder

3
New cards

DSM-5 criteria for GAD

· Excessive anxiety and worry lasting at least 6 months and difficulty controlling the worry

· At least 3 of the following symptoms

o Feeling keyed up or on edge, unsettled

o Becoming easily exhausted

o Mind going blank, difficulty focusing

o Impatience

o Muscle tension

o Sleep disturbance, usually insomnia

· Focus of the anxiety and worry are not caused by another anxiety or psychiatric disorder

· Significant distress or functional impairment because of anxiety symptoms

· Symptoms are not caused by a substance or general medical condition

4
New cards

psychological and cognitive signs and symptoms of GAD

· Excessive anxiety

· Worries that are difficult to control

· Feeling keyed up or on edge

· Poor concentration or mind going blank

· Restlessness

Irritability

5
New cards

physical signs and symptoms of GAD

· Fatigue

· Muscle tension

Sleep disturbance

6
New cards

impairing signs and symptoms of GAD

· Social, occupational or other important functional areas

Poor coping skills

7
New cards

Hamilton Anxiety Scale (HAM-A) reduction in symptoms for remission

>70% (or score <7)

8
New cards

HAM-A reduction in symptoms for improved clinical response

50-70%

9
New cards

HAM-A reduction in symptoms for partial clinical response

25-49%

10
New cards

HAM-A reduction in symptoms for non-response

<25%

11
New cards

risk factors for GAD

-gender (females>>)

-medications, herbal products, supplements (can worsen or even cause)

-medical conditions

· Socioeconomic and ethnic factors

· Recent stressful event

· Genetics

12
New cards

medications, herbal products, and supplements that can worsen or cause GAD

o Caffeine

o Corticosteroids

o Bupropion

o Stimulants

o Bronchodilators

o Decongestants

o Dopamine agonists

o Thyroid hormone

o Ginseng

o St. John's wort

o Nicotine

o Yohimbe

13
New cards

medical conditions that can cause GAD

o Cardio vascular

o Endocrine/metabolic

o Neurologic

o Respiratory

o Menopause/estrogen deficiency

14
New cards

where is GAD often treated?

in the primary care setting

15
New cards

clinical course of GAD

o Can occur at any age (avg is 35)

o Symptoms wax and wane

o >50% of pts with GAD will have a major depressive episode

16
New cards

what are the first-line treatments for GAD

SSRIs and SNRI's

17
New cards

what are the second-line treatments for GAD

o Alternative 1st line agent

o CBT (adjunct)

o Pregabalin

o Vilazodone

o Benzodiazepine

o Buspirone

18
New cards

what are the third-line treatments for GAD

o Alternative 2nd line agent

o Antihistamine (hydroxyzine)

o Second-generation antipsychotic, valproate, trazodone, TCA, vortioxetine

19
New cards

treatment pathway for GAD

20
New cards

SSRIs with the most evidence for treating GAD

-paroxetine

-escitalopram

-citalopram

-setraline

21
New cards

SNRIs with the most evidence for terating GAD

-venlafaxine

-desvenlafaxine

22
New cards

antidepressant onset and titration for GAD

o 4-12 weeks for response in GAD

o Many pts won't achieve remission

o Antidepressants may initially worsen anxiety symptoms consider starting at a lower dose

23
New cards

what line of teratment is CBT for GAD

2nd line

24
New cards

CBT efficacy as a 2nd line treatment of GAD

o Most effective psychological therapy

o Identify negative thought patterns that provoke or worsen anxiety symptoms

o Can be limited by cost, time requirement, availability of trained therapists

o Pharmacotherapy has shown to be more effective than psychotherapy

25
New cards

what type of therapy is most effective for GAD

pharmacotherapy>> psychotherapy

26
New cards

what's a precaution to consider with pregabalin

there is abuse/misuse potential especially in people with a history of SUD

27
New cards

onset of pregabalin

rapid ~1 week

28
New cards

ADRs of pregabalin

-dizziness

-somnolence

-ataxia

-blurred vision

-withdrawal with abrupt discontinuation

29
New cards

what line of therapy are benzodiazepiens for GAD

they are 2nd line but often prescibed because they provide rapid relief (30-60 mins)

30
New cards

precautions to know for benzodiazepine use in GAD

o Long term use is not recommended due to dependence and withdrawal symptoms

§ Withdrawal can occur after taking it for 4-6 weeks

§ Rebound anxiety

31
New cards

what is rebound anxiety

immediate, transient return of anxiety symptoms with increased anxiety compared to baseline when stopping consistent use of a benzodiazepine

32
New cards

rules for benzodiazepines

o May initiate benzos when starting an antidepressant for GAD until antidepressant begins to take effect (limit 2-3 weeks) or for treatment-resistant GAD

o Avoid if history of SUD

o Not effective for depression and may worsen depression/PTSD with long-term use

33
New cards

BZDs and depression

not effective and may worsen depression/PTSD with long-term use

34
New cards

which benzos are misused the most and why

diazepam because they have a rapid onset of action

35
New cards

adverse CNS effects of benzodiazepines

· Drowsiness, sedation

· Psychomotor impairment--> falls

· Disorientation, confusion

· Depression

· Irritability

Memory impairment

36
New cards

abuse, dependence, and withdrawal effects with benzodiazpeines

· High potential for abuse (CIV) especially if history of SUD

· Withdrawal symptoms

· Anxiety

· Insomnia

· Restlessness

· Muscle tension

· Irritability

Seizures (high dose, long duration of therapy, concurrent use with meds that lower seizure threshold)

37
New cards

abuse and benzodiazepines, who should you be cautious about giving these to?

people with a history of SUD because they have high abuse potential

38
New cards

what schedule are benzos?

CIV

39
New cards

which benzodiazepines are safe in patients with hepatic impairment?

· lorazepam, oxazepam, temazepam (LOT)

40
New cards

which drugs have additive CNS and respiratory depression when used with benzos?

alcohol and opioids

41
New cards

which drugs cause a decrease in concentraion of benzodiazepines

-phenytoin

-carbamazepine

-phenobarbital

42
New cards

which durgs cause an increase in concentration of benzodiazepines

CYP3A4 inhibitors (like fluoxetine)

may need to decrease the dose with these

43
New cards

what is the goal of benzo discontinuation

avoid withdrawal symptoms including seizures

44
New cards

tapering off of benzodiazepines

· Reduce dose by 25% per week until 50% of dose is reached

o Then reduce dose by 1/8 every 4-7 days

45
New cards

>8 weeks of BZD therapy, what is the optimal taper duration?

2-3 weeks

46
New cards

>6 months of BZD therapy, what is the optimal taper duration?

4-8 weeks

47
New cards

>1 year of BZD therapy, what is the optimal taper duration?

2-4 months

48
New cards

switchign meds in anxiety disorders, what should you do first if 1 first-line doesn't work?

o First try an alternative 1st-line med before switching to 2nd line

49
New cards

what line of teratment is busprione in GAd

2nd line

50
New cards

buspar generic name

buspirone

51
New cards

lyrica generic name

pregabalin

52
New cards

onset of buspirone in GAD

o Onset may take 2 weeks but full effect may take 4-6 weeks

53
New cards

long-term efficacy of busprione

inconsistent evidence of long-term efficacy

54
New cards

busprione is less likley to be effective if the patient has used ___ within the last ___

if they have used benzos within the last month

55
New cards

ADRs of busprione

dizziness, nausea, headache

56
New cards

initial dose of busprione

7.5mg BID

57
New cards

what patients is buspirone not recommended in?

hepatic or renal impairment

58
New cards

hydroxyzine brand names

atarax and vistaril

59
New cards

what line of treatment is hydroxyzine for GAD

3rd line

60
New cards

when can hydroxyzine be taken?

Symptomatic (prn) relief of anxiety or scheduled

61
New cards

ADRs of hydroxyzine

anticholineric and antihistamine effects including sedation

62
New cards

treatment duration for GAD

· Duration: >/=12 months after treatment response

· Gradually taper off of dose

63
New cards

panic disorder criteria

· recurrent unexpected panic attacks with >/= 1 attack followed by at least 1 month of more than 1 of the following

o Constant concern about having another attack

o Being anxious about the implications of the attack or its consequences

o Maladaptive behavior changes to avoid having panic attack

64
New cards

panic attack vs panic disorder

if you have one panic attack it doesn't necessarily mean you have panic disorder

65
New cards

agoraphobia criteria

· fear or anxiety in >/=2 of the following situations

o Public transportation

o Open spaces

o Enclosed places

o Crowds or standing in line

o Outside of home alone

66
New cards

phsychological symptoms of a panic attack

-depersonalization

-derealization

-fear or losing control, going crazy, dying

67
New cards

physical symptoms of panic attacks

o Abdominal distress, nausea

o Chest pain, palpitations, tachycardia

o Chills, hot flashes, sweating

o Dizziness, light-headedness

o Feeling of choking

o Shortness of breath

o Trembling or shaking

68
New cards

risk factors for panic disorder

o Gender (female more likely)

o Medications, herbal products, supplements (same as GAD)

o Environmental triggers

o Stressful life events

o Smoking

o Genetics (1st degree relative)

69
New cards

clinical course of PD

o Frequency of panic attacks may wax and wane in response to stressors

§ Most pts need long-term treatment

o 1/3 of pts achieve remission

o 1/5 of patients have chronic PD

70
New cards

what factors can predict chronic panic disorder

§ Long duration of illness

§ Severe agoraphobia

§ Comorbid personality, mood, or other anxiety disorders

§ Excessive sensitivity to physical symptoms

71
New cards

PD

panic disorder

72
New cards

first-line treatment for PD

· psychotherapy (CBT, exposure therapy) AND/OR medications (SSRI’s or venlafaxine)

o SSRI’s are equal efficacy- significant improvement in panic severity, anticipatory anxiety, agoraphobia, disability, and quality of life

o Pts may be hypersensitive to ADRs at initiation of treatment

73
New cards

2nd line treatment for PD

o Alt first-line agents

o Benzos for residual anxiety of rapid symptom control (if no SUD history)

o TCA’s- used if SSRI’s or venlafaxine is ineffective, but they have more side effects

o Exercise

74
New cards

when should benzos not be used as monotherapy

if pt has comorbid depression

75
New cards

which benzos are most commonly prescribed for PD?

alprazolam and clonazepam

76
New cards

third-line treatment of PD

o Alt 2nd-line agent

o Phenelzine (MAOI)

77
New cards

treatment goals of PD

o Reduce frequency and severity of panic attacks

o Reduce anticipatory anxiety, fear-driven avoidance, and impaired functioning

78
New cards

onset of antidepressant efficacy in PD

3-4 weeks (may be >6 months for full remission)

79
New cards

onset of BZD efficacy in PD

reduce acute anxiety within hours but may take. 4-6 weeks for full benefit as a monotherapy

80
New cards

duration of PD acute phase of therapy

1-4 months --> change treatment if no response after 12 weeks at max tolerated dose

81
New cards

duration of PD maintenance phase of therapy

continue for 12 months after treatment response

82
New cards

duration of PD discontinuation phase of therapy

depends on pt but taper over 4-6 months to avoid relapse

83
New cards

DSM-5 criteria for social anxiety disorder

· Significant anxiety/fear about at least 1 social situation where individual is exposed to possible scrutiny by others

· Fears they will display anxiety symptoms or act in a way that will be negatively assessed

· Social situations cause anxiety or fear

· Social situations are avoided or experienced with anxiety/fear

· Anxiety/fear > actual threat posed by the social situation

· Anxiety/fear/avoidance persists for >/= 6 months

· Symptoms cause impairment or distress

· Symptoms not caused by substance

· Symptoms> what would be expected from comorbid medical conditions

84
New cards

what must be specified about social anxiety disorder according to DSM-5 criteria?

must specify if it's performance-only social anxiety

85
New cards

fears of social anxiety disorder

- Scrutinized by others

- Embarrassment

Humiliation

86
New cards

feared situtations of social anxiety disorder

- Public speaking

- Eating/drinking in front of others

- Interacting with authority figures

- Talking with strangers

Use of public restrooms

87
New cards

physical symptoms of social anxiety

- Blushing

- "butterflies"

- Diarrhea

- Sweating

- Tachycardia

trembling

88
New cards

risk factors for social anxiety

· psych comorbidity

· genetics ( 1st-degree relative)

· familial factors (parental overcontrol)

· early childhood anxiety disorders

· life stressors

89
New cards

onset vs treatment of social anxiety

onset is usually 14-16 years old but treatment is delayed by about 10 years

90
New cards

comorbid conditions with social anxiety

anxiety, depression, SUD

91
New cards

pathophysiology of performance-only subtyoe of social anxiety

NE syetm dysfunction

92
New cards

SAD

social anxiety disorder

93
New cards

pathophysiology of general SAD

o decreased D2 receptor binding

o low DA metabolite levels--> higher incidence of SAD in Parkinson's pts and during antipsychotic treatment

o hypersensitive 5-HT2 receptors

94
New cards

first-line treatment of SAD

o CBT

o SSRI’s

§ Improve anxiety, avoidance, and disability

o Venlafaxine

95
New cards

which SNRIs are first-line for SAD

venlafaxine only

96
New cards

which SSRIs are first-line for SAD

paroxetine, sertraline, escitalopram, fluvoxamine

97
New cards

2nd-line treatment of SAD

o Alt 1st line agent

o Pregabalin

o Mirtazapine

o Gabapentin

98
New cards

efficacy of benzos/ antipsychotics in SAD

little evidence to support augmentation with benzos or antipsychotics but may be an option in pts with partial response

99
New cards

treatment options for performance-related SAD

beta blockers- propanolol and atenolol

100
New cards

what do beta blockers do in performance-related SAD pts

decrease tremor palpitations and blushing